Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Cross Country Healthcare (CCRN) EBIAT (2016 - 2025)

Cross Country Healthcare's EBIAT history spans 16 years, with the latest figure at -$82.9 million for Q4 2025.

  • For Q4 2025, EBIAT fell 2109.67% year-over-year to -$82.9 million; the TTM value through Dec 2025 reached -$94.9 million, down 551.64%, while the annual FY2025 figure was -$94.9 million, 551.64% down from the prior year.
  • EBIAT reached -$82.9 million in Q4 2025 per CCRN's latest filing, down from -$4.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $77.6 million in Q4 2021 to a low of -$82.9 million in Q4 2025.
  • Average EBIAT over 5 years is $14.2 million, with a median of $12.2 million recorded in 2021.
  • Peak YoY movement for EBIAT: soared 2141.2% in 2021, then tumbled 2109.67% in 2025.
  • A 5-year view of EBIAT shows it stood at $77.6 million in 2021, then crashed by 49.99% to $38.8 million in 2022, then tumbled by 76.7% to $9.0 million in 2023, then plummeted by 141.52% to -$3.8 million in 2024, then crashed by 2109.67% to -$82.9 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's EBIAT are -$82.9 million (Q4 2025), -$4.8 million (Q3 2025), and -$6.7 million (Q2 2025).